| 09:00-09:15 |
Borrowing Wisely: Stroke Learnings Applied to ARIA |
김예림(한림의대) |
| 09:15-09:30 |
Accelerating Drug Development for Neurodegeneration |
김재호(한림의대) |
| 09:30-09:45 |
Biomarkers of LATE (Limbic-Predominant TDP-43 Encephalopathy) |
전민영(연세의대) |
| 09:45-10:00 |
Lecanemab Subcutaneous Formulation in Early AD |
김한결(연세의대) |
| 10:00-10:15 |
Fluid Biomarkers of Co-Pathology in AD |
나한규(연세의대) |
| 10:15-10:30 |
Amyloid Biomarkers & Anti-Amyloid Therapy Eligibility |
김아련(충북의대) |
| 10:30-10:45 |
Brain-Shuttle Trontinemab: Long-Term Data & Secondary Prevention |
고판우(경북의대) |
| 10:45-11:00 |
휴식 |
| 11:00-11:15 |
Beyond GWAS: Rare & Complex Genomic Variation in AD |
김준표(성균관의대) |
| 11:15-11:30 |
Advances & Real-World Impact of Blood-Based Biomarkers |
홍윤정(가톨릭의대) |
| 11:30-11:45 |
Tau Therapeutics: Recent Trials & Next-Generation Pipeline |
정나연(부산의대) |
| 11:45-12:00 |
Immune: Vascular-Immune Interactions & Neuroimmune Targets |
정영희(한림의대) |
| 12:00-12:15 |
Lifestyle Intervention & Brain Health (US POINTER) |
김여진(한림의대) |
| 12:15-12:30 |
Neuropsychiatric Symptoms in AD: Manifestations & Biomarkers |
강성우(한양의대) |
